Ptpn1 deficiency collaborates with a NUP98::HOXD13 fusion gene to generate B cell precursor acute lymphoblastic leukemia
The Journal of Immunology · 01.10.2026 · 215 (10)
DOI: 10.1093/jimmun/vkag250 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Immunology, online erschienen am 13.10.2026. Verfasst von Nupur Nigam und 7 weiteren Autor:innen. Beteiligte Einrichtung: Genetics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States. Hauptthemen laut MEDLINE: Oncogene Proteins, Fusion, Precursor B-Cell Lymphoblastic Leukemia-Lymphoma, Protein Tyrosine Phosphatase, Non-Receptor Type 1, Homeodomain Proteins. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Intramural NIH HHS, NIH HHS, Intramural Research Program of the National Cancer Institute.
Abstract (Originalsprache)
B cell precursor acute lymphoblastic leukemia (BCP ALL) is driven by a combination of genetic alterations that promote invasion and expansion of undifferentiated B cells. Mice that express a NUP98::HOXD13 (NHD13) fusion gene in hematopoietic cells develop a wide range of hematologic malignancy, and when crossed to mice that are prone to develop copy number aberrations (CNA), develop BCP ALL, accompanied by homozygous mutations of Ptpn1. To determine if Ptpn1 deletion can be a causal event leading to BCP-ALL, we crossed NHD13 mice with Ptpn1−/− mice. Mice with NHD13 expression and homozygous Ptpn1 loss developed BCP ALL with a penetrance of 70%, suggesting that Ptpn1 can function as a tumor suppressor gene in this context. Moreover, NHD13/Ptpn1+/− mice that developed BCP ALL typically showed a loss of the Ptpn1 wild type allele in leukemia cells, supporting the assertion that Ptpn1 can function as a tumor suppressor gene. Whole exome sequencing revealed acquired mutations in pathways typically mutated in human BCP ALL, such as B cell differentiation, signal transduction, and cytokine signaling. Transcriptomic analysis indicated -upregulation of signaling pathways in mitochondrial reprogramming and oxidative phosphorylation. In conclusion, we demonstrate the role of Ptpn1 as a tumor suppressor in controlling the development of B cell malignancies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Genetics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States.
- Department of Biochemistry, McGill University, Montreal, QC, Canada.
- Sequencing Facility Bioinformatics Group, Advanced Biomedical and Computational Science, Frederick National Laboratory for Cancer Research, Frederick, MD, United States.
- Myeloid Malignancy Program (MMP), National Institutes of Health, Bethesda, MD, United States.
ORCID-Profile: Mianmian Yin, Peter D Aplan
Förderung
- Intramural NIH HHS
- NIH HHS
- Intramural Research Program of the National Cancer Institute
- National Institutes of Health
Zitieren
APA
Nigam, N., Matsukawa, T., Bertoli, R., Tremblay, M. L., Yin, M., Zhao, Y., Chung, Y. J., & Aplan, P. D. (2026). Ptpn1 deficiency collaborates with a NUP98::HOXD13 fusion gene to generate B cell precursor acute lymphoblastic leukemia. The Journal of Immunology, 215(10). https://doi.org/10.1093/jimmun/vkag250
Vancouver
Nigam N, Matsukawa T, Bertoli R, Tremblay ML, Yin M, Zhao Y, et al. Ptpn1 deficiency collaborates with a NUP98::HOXD13 fusion gene to generate B cell precursor acute lymphoblastic leukemia. The Journal of Immunology. 2026;215(10). doi:10.1093/jimmun/vkag250
BibTeX
@article{Nigam2026,
author = {Nigam, Nupur and Matsukawa, Toshihiro and Bertoli, Ryan and Tremblay, Michel L and Yin, Mianmian and Zhao, Yongmei and Chung, Yang Jo and Aplan, Peter D},
title = {Ptpn1 deficiency collaborates with a NUP98::HOXD13 fusion gene to generate B cell precursor acute lymphoblastic leukemia},
journal = {The Journal of Immunology},
year = {2026},
volume = {215},
number = {10},
doi = {10.1093/jimmun/vkag250}
}
EUVIMED